AGNELLI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 20.056
NA - Nord America 11.664
AS - Asia 10.261
SA - Sud America 863
AF - Africa 190
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 5
Totale 43.096
Nazione #
US - Stati Uniti d'America 11.336
DE - Germania 9.752
GB - Regno Unito 3.967
CN - Cina 3.748
SG - Singapore 2.593
IT - Italia 1.629
SE - Svezia 1.137
RU - Federazione Russa 1.020
HK - Hong Kong 787
VN - Vietnam 737
FR - Francia 657
IN - India 593
BR - Brasile 587
UA - Ucraina 417
BD - Bangladesh 410
TR - Turchia 409
NL - Olanda 372
KR - Corea 348
IE - Irlanda 316
FI - Finlandia 291
EU - Europa 241
CA - Canada 238
JP - Giappone 170
ID - Indonesia 140
CO - Colombia 139
DK - Danimarca 87
PL - Polonia 82
CI - Costa d'Avorio 72
GR - Grecia 66
AR - Argentina 54
AU - Australia 49
IQ - Iraq 49
ES - Italia 41
BE - Belgio 39
MX - Messico 39
PK - Pakistan 27
CH - Svizzera 26
AT - Austria 25
RO - Romania 24
UZ - Uzbekistan 24
ZA - Sudafrica 22
EC - Ecuador 21
EG - Egitto 21
CY - Cipro 20
PH - Filippine 20
MY - Malesia 19
JO - Giordania 17
MA - Marocco 17
CZ - Repubblica Ceca 16
IR - Iran 16
TW - Taiwan 16
VE - Venezuela 16
CL - Cile 15
AE - Emirati Arabi Uniti 14
KE - Kenya 14
SA - Arabia Saudita 14
NP - Nepal 13
TH - Thailandia 13
JM - Giamaica 12
NO - Norvegia 12
IL - Israele 11
PE - Perù 11
TN - Tunisia 11
BG - Bulgaria 10
PT - Portogallo 10
PY - Paraguay 10
HU - Ungheria 9
AL - Albania 8
AZ - Azerbaigian 8
CR - Costa Rica 8
GE - Georgia 7
LT - Lituania 7
NZ - Nuova Zelanda 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
LU - Lussemburgo 6
BO - Bolivia 5
DZ - Algeria 5
LB - Libano 5
TJ - Tagikistan 5
UY - Uruguay 5
PA - Panama 4
SC - Seychelles 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BS - Bahamas 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
Totale 43.285
Città #
Frankfurt am Main 6.859
Southend 3.459
Singapore 1.392
Ashburn 990
Beijing 868
Hong Kong 725
Chandler 715
Boise 651
Seattle 633
Milan 580
San Jose 562
Wilmington 440
Fairfield 439
Princeton 417
Dallas 352
Jacksonville 343
Council Bluffs 316
Dublin 312
Houston 290
Dearborn 276
Woodbridge 276
Hanover 271
Mountain View 248
Nanjing 237
Ho Chi Minh City 222
Redmond 219
Los Angeles 215
Bengaluru 207
Ann Arbor 203
Lauterbourg 182
Cambridge 178
Guangzhou 175
Hanoi 170
Somerville 167
New York 166
Shanghai 164
Toronto 155
Moscow 144
Des Moines 143
Serra 143
Andover 140
Santa Clara 140
Sakarya 137
Bogotá 125
Buffalo 120
Hefei 118
Boardman 114
Jinan 108
Helsinki 103
Shenyang 101
Tokyo 93
Berlin 92
Jakarta 92
Nanchang 83
Tianjin 79
Kiez 78
Phoenix 76
Redwood City 76
Changsha 73
Abidjan 72
Columbus 72
Cangzhou 67
The Dalles 63
Hebei 62
Warsaw 61
Hangzhou 59
Saint Petersburg 59
São Paulo 56
Zhengzhou 54
Athens 53
Nürnberg 53
Eitensheim 51
Rome 48
Munich 43
Roxbury 43
Wuhan 43
Naples 40
Nuremberg 40
Grafing 39
Hamburg 38
Odernheim 37
Bitonto 36
Kunming 35
Orofino 35
San Diego 35
Chengdu 34
Da Nang 34
Seoul 34
Shenzhen 33
London 32
Payette 32
Cottonwood 31
Fuzhou 31
Garden Valley 31
Atlanta 30
Jiaxing 30
Jerome 29
Orem 29
Chicago 28
Falls Church 28
Totale 28.212
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells : a new attractive target 1.034
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide 1.016
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 534
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 434
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 422
IMPROVED RISK STRATIFICATION IN MULTIPLE MYELOMA USING A MICRORNA-BASED CLASSIFIER 406
Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism 400
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma 396
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 385
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma 372
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing 352
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia 349
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma 343
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 340
Prognostic significance of telomere length in chronic lymphocytic leukemia patients in early stage disease 340
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 338
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 324
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 322
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma 321
Disentangling the microRNA regulatory milieu in multiple myeloma : integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 314
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 313
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 312
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 310
Long Non-Coding RNAs in Multiple Myeloma 294
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 291
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 290
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 289
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia 289
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 284
Genome-wide approach identify recurrent 8p21.2 loss in more aggressive form of primary plasma-cell leukemia 284
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 282
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek 280
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia 278
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 276
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 276
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 273
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma 273
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 272
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 272
B-cell receptor configuration and adverse cytogenetics are associated to a higher risk of autoimmune hemolytic anemia in the course of chronic lymphocytic leukemia 271
Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression 268
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 266
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles 265
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 264
Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine 261
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome 260
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 259
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes 257
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 255
Molecular definition of 17P11-P12 amplification in multiple myeloma 254
In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma 254
Integration of Transcriptional and Mutational Data Simplifies the Stratification of Peripheral T-Cell Lymphoma 254
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia 253
A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes 252
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses 251
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome 251
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 250
Patterns of global DNA methylation identify early stage (Binet A) CLL patients with higher risk of disease progression 246
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 245
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 242
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 242
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 238
Integrative genomic analysis of primary plasma cell leukemia revealed strong gene and microrna dosage effect 238
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia : a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 238
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma 237
Molecular classification of Multiple Myeloma : a distinct trascriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocation 236
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications 236
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 235
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 235
Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components 235
Integrative genomics based on microarrays analyses reveals a correlation between allelic imbalances and gene expression patterns in multiple myeloma 234
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 233
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma 231
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 230
The immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and rankl/opg ratio in myeloma microenvironment targeting the expression of adhesion molecules 229
The investigation of genomic profiles in primary plasma cell leukemias by means of an integrative microarray approach 229
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 228
Genome-wide DNA copy number analysis by SNP arrays of B-cell chronic lymphocytic leukemia reveals the presence of novel molecular lesions 228
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 228
Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia 227
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia 226
Molecular classification of multiple myeloma: a distinct profile characterizes patients expressing CCND1 and negative for 14q32 translocations 225
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 224
Bone microenvironment cells show a different pattern of gene expression profiling in relationship with the presence of osteolytic bone lesions in multiple myeloma patients 223
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 223
Stereotyped B-cell receptor is associated with immune thrombocytopenia in CLL 223
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia 220
Are the myeloma bone microevironment cells tumoral or not? 219
High-resolution microarray characterization of the 13q14 deletion extent in B-cell chronic lymphocytic leukemia : correlation with copy number and expression levels of mir-15a/16 cluster 219
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia 219
Transcriptional features of 1Q in multiple myeloma 218
The investigation of genomic profiles in plasma cell leukemias by means of an integrative microarray approach 218
Reconstruction of transcriptional regulatory networks in multiple myeloma 217
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion 216
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 215
Revealing the Impact of Structural Variants in Multiple Myeloma 215
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 214
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 214
Biological and clinical relevance of quantitative global methylation in repetitive DNA sequences in B-cell chronic lymphocytic leukemia 214
Prognostic significance of telomere lenght in chronic lymphocytic leukemia patients in early stage disease 213
Totale 28.600
Categoria #
all - tutte 100.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021998 0 0 0 0 0 0 0 0 0 0 738 260
2021/20222.642 207 93 169 149 245 185 282 170 354 206 134 448
2022/20232.742 411 263 223 270 317 545 87 166 235 55 112 58
2023/20246.235 55 136 91 166 478 275 946 863 427 871 933 994
2024/20256.202 897 828 756 692 247 160 154 439 254 404 365 1.006
2025/20268.598 878 598 883 733 786 574 1.097 464 940 615 1.030 0
Totale 44.829